Icon Wealth Advisors’s AbbVie ABBV Stock Holding History

Icon Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.25M	Sell	35,559 -6,948	-16%	-$1.54M	0.47%	42
2025 Q4	$9.68M	Buy	42,507 +659	+2%	+$150K	0.64%	36
2025 Q3	$9.69M	Sell	41,848 -842	-2%	-$171K	0.66%	36
2025 Q2	$7.92M	Buy	42,690 +3,238	+8%	+$602K	0.56%	36
2025 Q1	$8.27M	Buy	39,452 +107	+0.3%	+$20.8K	0.68%	33
2024 Q4	$6.99M	Buy	39,345 +581	+1%	+$107K	0.58%	35
2024 Q3	$7.66M	Buy	38,764 +618	+2%	+$115K	0.64%	29
2024 Q2	$7.07M	Buy	38,146 +2,538	+7%	+$420K	0.63%	31
2024 Q1	$6.48M	Sell	35,608 -118	-0.3%	-$20.3K	0.6%	32
2023 Q4	$5.54M	Buy	+35,726	New	+$5.21M	0.58%	31
2022 Q4	$8.72M	Buy	53,953 +1,780	+3%	+$273K	1%	17
2022 Q3	$7M	Buy	+52,173	New	+$7.49M	0.85%	19

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Icon Wealth Advisors's ABBV Position: Q1 2026 in Review

Icon Wealth Advisors reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $1.54M and leaving 35,559 shares worth $7.25M. The position accounts for 0.47% of the portfolio, ranked #42.

Icon Wealth Advisors first reported a position in ABBV in Q3 2022 and has held it in 12 quarters since. The position peaked at $9.69M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Icon Wealth Advisors held 35,559 shares of AbbVie worth $7.25M as of Q1 2026.
Icon Wealth Advisors sold 6,948 AbbVie shares in Q1 2026, an estimated $1.54M.
AbbVie made up 0.47% of Icon Wealth Advisors's portfolio in Q1 2026, its #42 holding.
Icon Wealth Advisors first reported a position in AbbVie in Q3 2022 and has held it in 12 quarters since.
Icon Wealth Advisors's AbbVie position peaked at $9.69M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Icon Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.